JP2015529211A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529211A5
JP2015529211A5 JP2015530374A JP2015530374A JP2015529211A5 JP 2015529211 A5 JP2015529211 A5 JP 2015529211A5 JP 2015530374 A JP2015530374 A JP 2015530374A JP 2015530374 A JP2015530374 A JP 2015530374A JP 2015529211 A5 JP2015529211 A5 JP 2015529211A5
Authority
JP
Japan
Prior art keywords
fusion polypeptide
sample
analyte
skp
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015530374A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015529211A (ja
JP6285934B2 (ja
Filing date
Publication date
Priority claimed from EP12006298.9A external-priority patent/EP2706115A1/en
Application filed filed Critical
Publication of JP2015529211A publication Critical patent/JP2015529211A/ja
Publication of JP2015529211A5 publication Critical patent/JP2015529211A5/ja
Application granted granted Critical
Publication of JP6285934B2 publication Critical patent/JP6285934B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015530374A 2012-09-06 2013-09-04 イムノアッセイの干渉の低減、及び安定化のためのシャペロン−シャペロン融合ポリペプチド Active JP6285934B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12006298.9A EP2706115A1 (en) 2012-09-06 2012-09-06 Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays
EP12006298.9 2012-09-06
PCT/EP2013/068269 WO2014037389A1 (en) 2012-09-06 2013-09-04 Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays

Publications (3)

Publication Number Publication Date
JP2015529211A JP2015529211A (ja) 2015-10-05
JP2015529211A5 true JP2015529211A5 (enExample) 2016-09-15
JP6285934B2 JP6285934B2 (ja) 2018-02-28

Family

ID=46963361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015530374A Active JP6285934B2 (ja) 2012-09-06 2013-09-04 イムノアッセイの干渉の低減、及び安定化のためのシャペロン−シャペロン融合ポリペプチド

Country Status (6)

Country Link
US (1) US10197559B2 (enExample)
EP (2) EP2706115A1 (enExample)
JP (1) JP6285934B2 (enExample)
CN (1) CN104583408B (enExample)
CA (1) CA2881411C (enExample)
WO (1) WO2014037389A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3427057A1 (en) * 2016-03-07 2019-01-16 H. Hoffnabb-La Roche Ag Detection of anti-p53 antibodies
ES2961462T3 (es) * 2017-07-27 2024-03-12 Roche Diagnostics Gmbh Proteína de fusión multiepítopo de un antígeno del VHC y usos de la misma
EP3684408A1 (en) 2017-09-19 2020-07-29 Massachusetts Institute of Technology Compositions for chimeric antigen receptor t cell therapy and uses thereof
CN115843334A (zh) 2020-04-23 2023-03-24 豪夫迈·罗氏有限公司 用于抗体免疫测定的冠状核衣壳抗原
JP2025517121A (ja) 2022-05-03 2025-06-03 エフ. ホフマン-ラ ロシュ アーゲー 免疫診断アッセイのためのHIV gp41バリアント
WO2025098623A1 (en) 2023-11-09 2025-05-15 Roche Diagnostics Gmbh Transglutaminase substrates for labeling

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4262594B2 (ja) 2001-06-22 2009-05-13 エフ.ホフマン−ラ ロシュ アーゲー レトロウイルス表面糖タンパク質を含む可溶性複合体
CA2636075C (en) * 2006-01-03 2011-11-08 F. Hoffmann-La Roche Ag Chimaeric fusion protein with superior chaperone and folding activities
PL2112158T3 (pl) * 2007-04-20 2012-03-30 Hoffmann La Roche Wykrywanie pierwotnych infekcji wywołanych patogenami
JP5461423B2 (ja) 2007-12-13 2014-04-02 エフ.ホフマン−ラ ロシュ アーゲー 新規風疹e1エンベロープタンパク質変異体および抗風疹抗体の検出におけるその使用
EP2127678A1 (en) 2008-05-26 2009-12-02 Roche Diagnostics GmbH SlpA as a tool for recombinant protein and enzyme technology

Similar Documents

Publication Publication Date Title
JP2015529211A5 (enExample)
EP4582812A3 (en) Assays for detecting the presence or amount of an anti-drug antibody
JP2016511417A5 (enExample)
MX2015012823A (es) Ensayo de combinacion de antigeno-anticuerpo del virus de la hepatitis c (vhc) y metodos y composiciones para usarlo.
JP2016528236A5 (enExample)
MX2015012824A (es) Antigenos recombinantes ns3 del vhc y mutantes de los mismos para la deteccion mejorada de anticuerpos.
WO2008027942A3 (en) Combination hepatitis c virus antigen and antibody detection method
JO3812B1 (ar) أجسام مضادة ترتبط بالمركب الترابطي البشري للموت المبرمج 1 (pd-l1)
JP2009284902A5 (enExample)
ZA202002415B (en) Detection of symmetrical dimethylarginine
MX2017011489A (es) Detección de moléculas pequeñas mediante nanoporos a través de ensayos de competición.
BR112015022844A8 (pt) método para determinar a presença ou ausência de anticorpos específicos do doador em uma amostra biológica, sistema e kit para praticar o mesmo
Ngubane et al. High-throughput sequencing enhanced phage display identifies peptides that bind mycobacteria
EA201892325A1 (ru) Композиции и способы детектирования белков клетки-хозяина
JP2017536846A5 (enExample)
MX353464B (es) Antigenos tpn47 de treponema pallidum, inmunoreactivos, solubles.
JP2013174612A5 (enExample)
JP2016528486A5 (enExample)
WO2018068064A3 (en) Mycobacterium tuberculosis proteins in diagnostic assays and devices for tuberculosis detection and diagnosis
JP2014524583A5 (enExample)
CN104650185A (zh) 一条与猪瘟e0蛋白相结合的多肽序列及其应用
Kim et al. A one-step immunoassay based on switching peptides for diagnosis of porcine epidemic diarrhea virus (PEDV) using screened Fv-antibodies
WO2015128394A3 (en) Soluble and immunoreactive variants of htlv capsid antigen p24
JP2017512200A5 (enExample)
WO2016069762A3 (en) Subject anti-hcv antibody detection assays employing ns3 capture peptides